Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/27/1990 | CA2056445A1 Injectable clarithromycin composition |
11/27/1990 | CA2017543A1 Polyethylene glycol derivatives, process for preparing the same and modified protein |
11/27/1990 | CA1276885C Medicament adsorbates and their preparation |
11/26/1990 | WO1990014080A1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester |
11/26/1990 | WO1990014076A1 A preparation for the treatment of fungal infections |
11/26/1990 | CA2067122A1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester |
11/26/1990 | CA2056622A1 Preparation for the treatment of fungal infections |
11/26/1990 | CA2017541A1 Polyethylene glycol derivatives, modified peptides and production thereof |
11/25/1990 | WO1990014433A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas |
11/25/1990 | CA2017442A1 Transdermal therapeutic composition |
11/24/1990 | CA2017360A1 Porous pharmaceutical form and preparation thereof |
11/24/1990 | CA2017355A1 Imipramine based composition |
11/24/1990 | CA2016911A1 Hypoallergenic steroidal anesthetic/hypnotic compositions |
11/23/1990 | CA2017307A1 Process for preparing aromatic ethers |
11/22/1990 | EP0398619A2 Stabilized compositions containing epidermal growth factor |
11/22/1990 | EP0398489A2 Film-forming emulsion containing iodine and methods of use |
11/22/1990 | EP0398472A2 Biodegradable polyurethanes |
11/22/1990 | EP0398305A2 Anthracycline conjugates having a novel linker and methods for their production |
11/22/1990 | EP0398288A2 Process for preparing optically active 2-arylalkanoic acids, in particular 2-arylpropionic acids |
11/22/1990 | EP0398287A1 Pharmaceutical preparation |
11/22/1990 | EP0398207A1 Stable liquid form of 5-aminosalicylic acid |
11/22/1990 | EP0398033A1 Oral preparation |
11/22/1990 | EP0398024A1 Conjugates for tumor localization and/or tumortherapy |
11/22/1990 | EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment |
11/22/1990 | EP0397798A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
11/21/1990 | CN1047035A Novel antibody system for biological response modifiers |
11/20/1990 | US4972037 Polysiloxane-grafted copolymer topical binder composition with novel fluorochemical comonomer and method of coating therewith |
11/20/1990 | US4971804 Antilipemic agents, antiprotein agents, mixures with waxes |
11/20/1990 | US4971802 Liposomes of synthetic lipids |
11/20/1990 | US4971800 Drug delivery through skin, penetration |
11/20/1990 | US4971798 Antitussive, decongestant, antihistamine or expectorant |
11/20/1990 | US4971797 Sweeteners of chlorosucrose cocrystallized with cyclodextrin |
11/20/1990 | US4971795 Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype |
11/20/1990 | US4971789 Ionic polyethers, process for preparing them and compositions in which they are present |
11/20/1990 | US4971785 Non-alcoholic delivery system for orally ingestible active ingredients |
11/20/1990 | US4971721 Water-oil-water emulsion; polyglycerol polyricinoleate emulsifier |
11/20/1990 | US4971079 Chewing gum for addiction to nicotine |
11/20/1990 | CA1276561C Compositions for cosmetic and dermatology comprising perfluoropolyethers |
11/20/1990 | CA1276554C Antitumor film from biodegradable polymers |
11/17/1990 | CA2016962A1 Polypeptide-antibody conjugate for inhibiting cell adhesion |
11/16/1990 | WO1990014105A1 Accumulation of drugs into liposomes by a proton gradient |
11/16/1990 | CA2056435A1 Accumulation of drugs into liposomes by a proton gradient |
11/16/1990 | CA2016888A1 Pharmaceutical preparation |
11/16/1990 | CA2016887A1 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl propionic acids |
11/15/1990 | WO1990013328A1 Dry powder inhalation device |
11/15/1990 | WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
11/15/1990 | WO1990013289A1 Antineoplastic solution and method for treating neoplasms |
11/15/1990 | WO1990013287A1 Use of c-20 to c-26 aliphatic alcohols in the treatment of viral infections |
11/15/1990 | DE3922021A1 Hard gelatin capsules contg. nifedipine - as soln. in carrier not causing embrittlement |
11/15/1990 | DE3915535A1 Compsns. for treating skin disorders - contain trigonellin or trigonellic acid |
11/15/1990 | CA2354096A1 Dry powder inhalation device |
11/15/1990 | CA2016825A1 Stable liquid form of 5-aminosalicylic acid |
11/14/1990 | EP0397542A1 Stabilization process for hydrated lamellar phases |
11/14/1990 | EP0397447A1 Pharmaceutical compositions |
11/14/1990 | EP0397409A1 The stabilization of organic compounds |
11/14/1990 | EP0397307A2 Water soluble high molecular polymerized drug preparation |
11/14/1990 | EP0397227A1 Method of preparation of an antimicrobial particulate, its product and applications |
11/14/1990 | EP0397211A2 Percutaneous administration of 3'-azide-3'-deoxythymidine |
11/14/1990 | EP0397147A2 Stable solutions of rebeccamycin analog and preparation thereof |
11/14/1990 | EP0396903A2 Use of IFN-gamma for the preparation of a pharmaceutical composition for the treatment of ATL |
11/14/1990 | EP0396777A1 Interferon preparation for nasal administration |
11/13/1990 | US4970298 Wound healing agents, crosslinked collagen sponge |
11/13/1990 | US4970288 Non-toxic polyester compositions made with organotin esterification catalysts |
11/13/1990 | US4970252 Polysiloxane, hydrocarbon oil |
11/13/1990 | US4970235 Medicaments containing of linolenic acid |
11/13/1990 | US4970230 Drugs containing a psoralene derivative |
11/13/1990 | US4970206 Pyroglutamic acid esters used as dermal penetration enhancers for drugs |
11/13/1990 | US4970078 Crosslinked carboxymethyguar tablet disintegrant |
11/13/1990 | CA1276109C Immunogenic conjugates |
11/13/1990 | CA1276108C Process for modifying ribosome-inactivating glycoproteins by oxidation of their osidic units and formation of a schiff's base |
11/13/1990 | CA1276107C Sustained release tablets of theophylline |
11/11/1990 | WO1990013645A1 Production in bacteria and yeast of hemoglobin and analogues thereof |
11/11/1990 | WO1990013571A1 Antifreeze polypeptides |
11/11/1990 | CA2056434A1 Antifreeze polypeptides |
11/09/1990 | WO1990013222A1 Plant protecting preparations, veterinary and additive preparations |
11/09/1990 | CA2032503A1 Compositions |
11/08/1990 | DE3914622A1 Prodn. of solid pharmaceutical or cosmetic compsns. - by extracting plants, animal organs and/or tissue cultures, opt. concentrating extract and mixing with lipophilic carrier |
11/08/1990 | CA2016165A1 Stabilization of organic compounds |
11/07/1990 | EP0396434A1 Compositions with cytolytic properties specific for appropriate target cells and their use |
11/07/1990 | EP0396429A2 Polyurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
11/07/1990 | EP0396406A2 Pharmaceutical formulations employing esterified alkoxylated polyols as vehicles |
11/07/1990 | EP0396387A2 A novel antibody delivery system for biological response modifiers |
11/07/1990 | EP0396188A1 Antibodies against fibrin; immunogenic peptides suitable for preparing the antibodies, method for determining fibrin and pharmaceutical preparation based on the antibodies |
11/07/1990 | EP0396184A2 Use of ketoconazole and a retinoid for the treatment of acne vulgaris |
11/07/1990 | EP0396169A2 Pharmaceutical composition for topical ophthalmic use having improved local tolerability |
11/07/1990 | EP0396165A1 Orally administered pharmaceutical composition for use in gastrointestinal washes, in particular for diagnostic use, or as cathartic laxative |
11/07/1990 | EP0395918A2 Plasminogen activator complex of pure pro-urokinase covalently bound by a disulfide bridge to human serum albumin |
11/07/1990 | CN1010279B Process for preparing injection medical composition containing active spergualin ingredient |
11/06/1990 | US4968675 Side effect reduction of triene steroid |
11/06/1990 | US4968617 Solid hydrochloride salt of t-PA |
11/06/1990 | US4968616 Superoxide dismutase derivatives, method of producing same and medicinal use of same |
11/06/1990 | US4968495 Chemically modified bilirubin oxidase |
11/06/1990 | CA1275933C Therapeutic composition containing ibuprofen |
11/06/1990 | CA1275932C Solution containing luprostiol |
11/06/1990 | CA1275930C Therapeutic agents containing 2-(2-fluoro-4-biphenylyl)-propionic acid |
11/05/1990 | WO1990013256A1 Method for localization and treatment of tumors and complexes therefor |
11/05/1990 | CA2032169A1 Method for localization and treatment of tumors and complexes therefor |
11/03/1990 | WO1990013310A1 Improved forms of basic fibroblast growth factor |
11/03/1990 | CA2055462A1 Improved forms of basic fibroblast growth factor |
11/02/1990 | WO1990013780A1 Very low temperature casting of controlled release microspheres |